首页 > 最新文献

Baylor University Medical Center Proceedings最新文献

英文 中文
Institution of a formal multidisciplinary heart team for high-risk coronary revascularization. 建立一个正式的多学科心脏小组来治疗高危冠状动脉血管重建术。
Q3 Medicine Pub Date : 2024-11-22 eCollection Date: 2025-01-01 DOI: 10.1080/08998280.2024.2426925
Srinivasa Potluri, Rahul Sawhney, Cody Dorton, Kyle McCullough, Ghadi Moubarak, Emily Shih, Jared Christensen, J Michael DiMaio, Karim Al-Azizi, Chadi Dib, Sameh Sayfo, Molly Szerlip, Sibi Thomas, Alfred Levy, Kelly Hutcheson, Melissa Carranza, Samantha Douthit, Trent Pettijohn, William Ryan, Michael Mack

Introduction: The heart team approach is now the standard of care for patients with complex coronary artery disease; however, the definition of a heart team is variable. We embarked on a project to create an extended, multidisciplinary heart team to evaluate patients we deemed high risk for coronary revascularization. In doing so, we created a new service, workflow, and paradigm.

Methods: Herein, we describe the process through which we created our high-risk percutaneous coronary intervention team, our criteria for determining risk, our process for evaluating these patients, and quality assurance. Additionally, we describe the design of our prospective study assessing 200 patients with complex coronary artery disease. The primary outcomes include the final heart team revascularization decision, all-cause mortality, major adverse cardiac events, acute kidney injury, postintervention bleeding, and length of stay.

Conclusion: Establishing a multidisciplinary heart team may help with complex and high-risk patient and family scenarios and potentially improve patient outcomes. A study has been initiated to test this hypothesis formally.

导读:心脏小组方法现在是复杂冠状动脉疾病患者的标准护理;然而,心脏小组的定义是可变的。我们开始了一个项目,创建一个扩展的,多学科的心脏团队来评估我们认为有冠状动脉血管重建术高风险的病人。在这样做的过程中,我们创建了一个新的服务、工作流和范式。方法:在本文中,我们描述了我们创建高危经皮冠状动脉介入治疗团队的过程,我们确定风险的标准,我们评估这些患者的过程,以及质量保证。此外,我们描述了对200例复杂冠状动脉疾病患者进行前瞻性研究的设计。主要结局包括最终的心脏小组血运重建决定、全因死亡率、主要心脏不良事件、急性肾损伤、干预后出血和住院时间。结论:建立一个多学科的心脏团队可能有助于处理复杂和高风险的患者和家庭情况,并有可能改善患者的预后。一项研究已经开始正式验证这一假设。
{"title":"Institution of a formal multidisciplinary heart team for high-risk coronary revascularization.","authors":"Srinivasa Potluri, Rahul Sawhney, Cody Dorton, Kyle McCullough, Ghadi Moubarak, Emily Shih, Jared Christensen, J Michael DiMaio, Karim Al-Azizi, Chadi Dib, Sameh Sayfo, Molly Szerlip, Sibi Thomas, Alfred Levy, Kelly Hutcheson, Melissa Carranza, Samantha Douthit, Trent Pettijohn, William Ryan, Michael Mack","doi":"10.1080/08998280.2024.2426925","DOIUrl":"10.1080/08998280.2024.2426925","url":null,"abstract":"<p><strong>Introduction: </strong>The heart team approach is now the standard of care for patients with complex coronary artery disease; however, the definition of a heart team is variable. We embarked on a project to create an extended, multidisciplinary heart team to evaluate patients we deemed high risk for coronary revascularization. In doing so, we created a new service, workflow, and paradigm.</p><p><strong>Methods: </strong>Herein, we describe the process through which we created our high-risk percutaneous coronary intervention team, our criteria for determining risk, our process for evaluating these patients, and quality assurance. Additionally, we describe the design of our prospective study assessing 200 patients with complex coronary artery disease. The primary outcomes include the final heart team revascularization decision, all-cause mortality, major adverse cardiac events, acute kidney injury, postintervention bleeding, and length of stay.</p><p><strong>Conclusion: </strong>Establishing a multidisciplinary heart team may help with complex and high-risk patient and family scenarios and potentially improve patient outcomes. A study has been initiated to test this hypothesis formally.</p>","PeriodicalId":8828,"journal":{"name":"Baylor University Medical Center Proceedings","volume":"38 1","pages":"28-33"},"PeriodicalIF":0.0,"publicationDate":"2024-11-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11657062/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142875611","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Barriers to guideline implementation. 指导方针实施的障碍。
Q3 Medicine Pub Date : 2024-11-22 eCollection Date: 2025-01-01 DOI: 10.1080/08998280.2024.2429285
Jennifer Freeman
{"title":"Barriers to guideline implementation.","authors":"Jennifer Freeman","doi":"10.1080/08998280.2024.2429285","DOIUrl":"10.1080/08998280.2024.2429285","url":null,"abstract":"","PeriodicalId":8828,"journal":{"name":"Baylor University Medical Center Proceedings","volume":"38 1","pages":"47"},"PeriodicalIF":0.0,"publicationDate":"2024-11-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11657056/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142876153","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Refining post-cesarean delivery pain management. 改进剖宫产后疼痛管理。
Q3 Medicine Pub Date : 2024-11-19 eCollection Date: 2025-01-01 DOI: 10.1080/08998280.2024.2426411
Robert White, Marcia Chen, Jaime Aaronson
{"title":"Refining post-cesarean delivery pain management.","authors":"Robert White, Marcia Chen, Jaime Aaronson","doi":"10.1080/08998280.2024.2426411","DOIUrl":"10.1080/08998280.2024.2426411","url":null,"abstract":"","PeriodicalId":8828,"journal":{"name":"Baylor University Medical Center Proceedings","volume":"38 1","pages":"5-6"},"PeriodicalIF":0.0,"publicationDate":"2024-11-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11657064/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142875983","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
T1 erector spinae plane block for resection of the rib in thoracic outlet syndrome. 胸出口综合征中T1直肌脊柱平面阻滞术切除肋骨。
Q3 Medicine Pub Date : 2024-11-13 eCollection Date: 2025-01-01 DOI: 10.1080/08998280.2024.2418745
Raghuraman M Sethuraman, Akash Babu, Shruthi Vinothkumar
{"title":"T1 erector spinae plane block for resection of the rib in thoracic outlet syndrome.","authors":"Raghuraman M Sethuraman, Akash Babu, Shruthi Vinothkumar","doi":"10.1080/08998280.2024.2418745","DOIUrl":"10.1080/08998280.2024.2418745","url":null,"abstract":"","PeriodicalId":8828,"journal":{"name":"Baylor University Medical Center Proceedings","volume":"38 1","pages":"118-119"},"PeriodicalIF":0.0,"publicationDate":"2024-11-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11657111/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142875916","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Physicians' attitudes toward gastroprotective strategies for nonsteroidal anti-inflammatory drug prescription. 医师对非甾体抗炎药处方胃保护策略的态度。
Q3 Medicine Pub Date : 2024-11-12 eCollection Date: 2025-01-01 DOI: 10.1080/08998280.2024.2418779
Fatima Abdeljaleel, Majd M AlBarakat, Elham Abdel Jalil, Zaid Al-Fakhouri, Ala Abdel Jalil

Introduction: There is a paucity of information regarding providers' attitudes toward gastric-protective strategies with concurrent use of nonsteroidal anti-inflammatory drugs (NSAIDs). We aimed to assess gastric-protective strategies used upon prescribing NSAIDs and providers' awareness of societal guidelines for preventing NSAID-induced gastric complications.

Methods: A standardized 10-item questionnaire was sent to all orthopedic providers in North Carolina and South Carolina. The survey design and refinement were based on a literature review, item generation, and small and large focus group discussions.

Results: Forty-two orthopedists responded to the survey (response rate 16%). The most frequently used NSAIDs were meloxicam (79%), naproxen (69%), and ibuprofen (64%). NSAIDs were most commonly prescribed on an as-needed basis (52%), followed by <3 months (43%). The most common indications were degenerative arthritis (95%) and herniated disk (45%). Gastrointestinal adverse effects of NSAIDs were managed by discontinuing NSAID therapy (73%) or switching to a cyclooxygenase-2 (COX-2) inhibitor (40%). A small proportion were managed by referring to another physician (36%). Some clinicians prescribed gastric prophylaxis for patients at high risk for NSAID-induced gastric complications (24%). The academic setting was significantly associated with gastric prophylaxis and frequent assessment for NSAID-induced gastric adverse events. Providers with >20 years of experience showed similar trends. In low-risk patients, compliance with gastroprotective prophylaxis prescription was low (5%). Most providers were unaware of the societal guidelines for NSAID-induced gastric complications or the preventive strategies.

Conclusion: Prescription of gastric-protective medications with concurrent NSAID therapy is relatively low among orthopedists. Academic setting and higher years of experience showed a significant trend toward more gastric-protective medication prescription, COX-2 inhibitor use, and frequent assessments for gastric adverse events when prescribing NSAID therapy. Provider education on the latest societal guidelines and computer-based alerts can increase compliance and assessment for NSAID-induced gastric complications and preventive strategies.

关于提供者对同时使用非甾体抗炎药(NSAIDs)的胃保护策略的态度的信息缺乏。我们的目的是评估在处方非甾体抗炎药时使用的胃保护策略,以及提供者对预防非甾体抗炎药引起的胃并发症的社会指南的认识。方法:向北卡罗来纳州和南卡罗来纳州的所有骨科服务提供者发送标准化的10项问卷。调查的设计和改进是基于文献回顾、项目生成和小型和大型焦点小组讨论。结果:42名骨科医生回复调查,回复率为16%。最常用的非甾体抗炎药是美洛昔康(79%)、萘普生(69%)和布洛芬(64%)。非甾体抗炎药是最常见的按需处方(52%),其次是20年的经验显示了类似的趋势。在低风险患者中,胃保护性预防处方的依从性较低(5%)。大多数提供者不知道非甾体抗炎药引起的胃并发症的社会指南或预防策略。结论:骨科医生在服用非甾体抗炎药的同时使用胃保护药物的比例相对较低。学术背景和较高的经验表明,在处方非甾体抗炎药治疗时,更多的胃保护药物处方、COX-2抑制剂的使用以及对胃不良事件的频繁评估有明显的趋势。提供者教育最新的社会指南和基于计算机的警报可以提高非甾体抗炎药引起的胃并发症和预防策略的依从性和评估。
{"title":"Physicians' attitudes toward gastroprotective strategies for nonsteroidal anti-inflammatory drug prescription.","authors":"Fatima Abdeljaleel, Majd M AlBarakat, Elham Abdel Jalil, Zaid Al-Fakhouri, Ala Abdel Jalil","doi":"10.1080/08998280.2024.2418779","DOIUrl":"10.1080/08998280.2024.2418779","url":null,"abstract":"<p><strong>Introduction: </strong>There is a paucity of information regarding providers' attitudes toward gastric-protective strategies with concurrent use of nonsteroidal anti-inflammatory drugs (NSAIDs). We aimed to assess gastric-protective strategies used upon prescribing NSAIDs and providers' awareness of societal guidelines for preventing NSAID-induced gastric complications.</p><p><strong>Methods: </strong>A standardized 10-item questionnaire was sent to all orthopedic providers in North Carolina and South Carolina. The survey design and refinement were based on a literature review, item generation, and small and large focus group discussions.</p><p><strong>Results: </strong>Forty-two orthopedists responded to the survey (response rate 16%). The most frequently used NSAIDs were meloxicam (79%), naproxen (69%), and ibuprofen (64%). NSAIDs were most commonly prescribed on an as-needed basis (52%), followed by <3 months (43%). The most common indications were degenerative arthritis (95%) and herniated disk (45%). Gastrointestinal adverse effects of NSAIDs were managed by discontinuing NSAID therapy (73%) or switching to a cyclooxygenase-2 (COX-2) inhibitor (40%). A small proportion were managed by referring to another physician (36%). Some clinicians prescribed gastric prophylaxis for patients at high risk for NSAID-induced gastric complications (24%). The academic setting was significantly associated with gastric prophylaxis and frequent assessment for NSAID-induced gastric adverse events. Providers with >20 years of experience showed similar trends. In low-risk patients, compliance with gastroprotective prophylaxis prescription was low (5%). Most providers were unaware of the societal guidelines for NSAID-induced gastric complications or the preventive strategies.</p><p><strong>Conclusion: </strong>Prescription of gastric-protective medications with concurrent NSAID therapy is relatively low among orthopedists. Academic setting and higher years of experience showed a significant trend toward more gastric-protective medication prescription, COX-2 inhibitor use, and frequent assessments for gastric adverse events when prescribing NSAID therapy. Provider education on the latest societal guidelines and computer-based alerts can increase compliance and assessment for NSAID-induced gastric complications and preventive strategies.</p>","PeriodicalId":8828,"journal":{"name":"Baylor University Medical Center Proceedings","volume":"38 1","pages":"42-46"},"PeriodicalIF":0.0,"publicationDate":"2024-11-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11657060/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142875969","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Aceruloplasminemia as a rare hereditary disease: four case reports in a single center.
Q3 Medicine Pub Date : 2024-11-12 eCollection Date: 2025-01-01 DOI: 10.1080/08998280.2024.2423506
Zülal İstemihan, Ziya İmanov, Bilger Çavuş, Aslı Çifcibaşı Örmeci, Filiz Akyüz, Fatih Beşışık, Sabahattin Kaymakoğlu, Kadir Demir

Aceruloplasminemia, which is a very rare iron metabolism disorder, may present with extremely nonspecific complaints, and disease screening should be considered, especially in patients with consanguineous marriages. We share four cases diagnosed with aceruloplasminemia and their characteristics. The first three cases were related to each other and have consanguineous marriages in their family history. Our first and fourth cases were diagnosed with aceruloplasminemia upon detecting hypochromic microcytic anemia, low transferrin saturation, and a high ferritin level in the examinations performed after a nonspecific complaint such as fatigue. Even though the second and third cases had no complaints, they were diagnosed during screening tests because they were relatives of the first case.

{"title":"Aceruloplasminemia as a rare hereditary disease: four case reports in a single center.","authors":"Zülal İstemihan, Ziya İmanov, Bilger Çavuş, Aslı Çifcibaşı Örmeci, Filiz Akyüz, Fatih Beşışık, Sabahattin Kaymakoğlu, Kadir Demir","doi":"10.1080/08998280.2024.2423506","DOIUrl":"10.1080/08998280.2024.2423506","url":null,"abstract":"<p><p>Aceruloplasminemia, which is a very rare iron metabolism disorder, may present with extremely nonspecific complaints, and disease screening should be considered, especially in patients with consanguineous marriages. We share four cases diagnosed with aceruloplasminemia and their characteristics. The first three cases were related to each other and have consanguineous marriages in their family history. Our first and fourth cases were diagnosed with aceruloplasminemia upon detecting hypochromic microcytic anemia, low transferrin saturation, and a high ferritin level in the examinations performed after a nonspecific complaint such as fatigue. Even though the second and third cases had no complaints, they were diagnosed during screening tests because they were relatives of the first case.</p>","PeriodicalId":8828,"journal":{"name":"Baylor University Medical Center Proceedings","volume":"38 2","pages":"195-198"},"PeriodicalIF":0.0,"publicationDate":"2024-11-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11844920/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143482185","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Assessing risk factors for peripartum quantified blood loss. 评估围生期定量失血的危险因素。
Q3 Medicine Pub Date : 2024-11-11 eCollection Date: 2025-01-01 DOI: 10.1080/08998280.2024.2426368
Belinda Kohl-Thomas, Jessica Ehrig
{"title":"Assessing risk factors for peripartum quantified blood loss.","authors":"Belinda Kohl-Thomas, Jessica Ehrig","doi":"10.1080/08998280.2024.2426368","DOIUrl":"10.1080/08998280.2024.2426368","url":null,"abstract":"","PeriodicalId":8828,"journal":{"name":"Baylor University Medical Center Proceedings","volume":"38 1","pages":"15"},"PeriodicalIF":0.0,"publicationDate":"2024-11-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11657112/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142876146","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Strongyloides stercoralis testing in transplant candidates. 移植候选者的粪类圆线虫检测。
Q3 Medicine Pub Date : 2024-11-11 eCollection Date: 2025-01-01 DOI: 10.1080/08998280.2024.2426360
Craig Rosenstengle, Shivang Mehta
{"title":"<i>Strongyloides stercoralis</i> testing in transplant candidates.","authors":"Craig Rosenstengle, Shivang Mehta","doi":"10.1080/08998280.2024.2426360","DOIUrl":"10.1080/08998280.2024.2426360","url":null,"abstract":"","PeriodicalId":8828,"journal":{"name":"Baylor University Medical Center Proceedings","volume":"38 1","pages":"26-27"},"PeriodicalIF":0.0,"publicationDate":"2024-11-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11657109/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142876144","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Urrets-Zavalia syndrome and secondary acute-angle closure glaucoma induced by implantable collamer lens.
Q3 Medicine Pub Date : 2024-11-08 eCollection Date: 2025-01-01 DOI: 10.1080/08998280.2024.2418729
Sruti S Rachapudi, Michael Herron, Noor A Laylani, Pamela A Davila-Siliezar, Andrew G Lee

Implantable collamer lenses (ICL) have revolutionized the management of high refractive errors, yet they present unique challenges. We present a case of a fixed and dilated atonic pupil following acute-angle closure glaucoma from pupillary block after ICL implantation, known as Urrets-Zavalia syndrome. A 39-year-old woman developed acute ocular pain and headaches after surgery, leading to elevated intraocular pressure and subsequent complications necessitating ICL removal. This case highlights the need for prompt identification and management of elevated intraocular pressure to prevent irreversible complications such as Urrets-Zavalia syndrome following ICL implantation.

植入式角膜塑形镜(ICL)彻底改变了高度屈光不正的治疗,但也带来了独特的挑战。我们介绍了一例因植入 ICL 后瞳孔阻滞而导致急性闭角型青光眼的固定性瞳孔散大无张力病例,即 Urrets-Zavalia 综合征。一名 39 岁的女性在手术后出现急性眼痛和头痛,导致眼压升高,随后出现并发症,不得不将 ICL 取出。本病例强调了及时发现和处理眼压升高的必要性,以防止出现不可逆转的并发症,如 ICL 植入术后的 Urrets-Zavalia 综合征。
{"title":"Urrets-Zavalia syndrome and secondary acute-angle closure glaucoma induced by implantable collamer lens.","authors":"Sruti S Rachapudi, Michael Herron, Noor A Laylani, Pamela A Davila-Siliezar, Andrew G Lee","doi":"10.1080/08998280.2024.2418729","DOIUrl":"10.1080/08998280.2024.2418729","url":null,"abstract":"<p><p>Implantable collamer lenses (ICL) have revolutionized the management of high refractive errors, yet they present unique challenges. We present a case of a fixed and dilated atonic pupil following acute-angle closure glaucoma from pupillary block after ICL implantation, known as Urrets-Zavalia syndrome. A 39-year-old woman developed acute ocular pain and headaches after surgery, leading to elevated intraocular pressure and subsequent complications necessitating ICL removal. This case highlights the need for prompt identification and management of elevated intraocular pressure to prevent irreversible complications such as Urrets-Zavalia syndrome following ICL implantation.</p>","PeriodicalId":8828,"journal":{"name":"Baylor University Medical Center Proceedings","volume":"38 2","pages":"191-194"},"PeriodicalIF":0.0,"publicationDate":"2024-11-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11845084/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143481987","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Hardware tools in dermatology: a gateway to accessible treatment. 皮肤病中的硬件工具:通向可及治疗的门户。
Q3 Medicine Pub Date : 2024-11-08 eCollection Date: 2025-01-01 DOI: 10.1080/08998280.2024.2426431
Kritin K Verma, Michelle B Tarbox, Daniel M Siegel
{"title":"Hardware tools in dermatology: a gateway to accessible treatment.","authors":"Kritin K Verma, Michelle B Tarbox, Daniel M Siegel","doi":"10.1080/08998280.2024.2426431","DOIUrl":"10.1080/08998280.2024.2426431","url":null,"abstract":"","PeriodicalId":8828,"journal":{"name":"Baylor University Medical Center Proceedings","volume":"38 1","pages":"110-112"},"PeriodicalIF":0.0,"publicationDate":"2024-11-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11657148/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142876116","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Baylor University Medical Center Proceedings
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1